San Francisco, CA, United States of America

Menno VanLookeren

USPTO Granted Patents = 3 

Average Co-Inventor Count = 16.6

ph-index = 3

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 2003-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Menno VanLookeren: Innovator in Therapeutic Polypeptides

Introduction

Menno VanLookeren, an accomplished inventor based in San Francisco, California, is known for his significant contributions to the field of biomedicine. With a portfolio that includes three patents, he has focused on developing novel solutions for degenerative cartilaginous disorders and inflammatory diseases.

Latest Patents

Menno's latest patents showcase his dedication to advancing medical science. One notable invention is titled "Nucleic acids encoding receptor for IL-17 homologous polypeptides and therapeutic uses thereof." This invention centers on novel polypeptides that have sequence identity with IL-17 and IL-17 receptors. It includes methods for producing these polypeptides, vectors, and host cells comprising the nucleic acid sequences, chimeric polypeptide molecules, and antibodies that interact with these new polypeptides. Additionally, it provides therapeutic methods for treating degenerative cartilaginous disorders and other inflammatory diseases.

Another significant patent pertains to "IL-17 related mammalian cytokine polypeptides (IL-17E)." Similar to his previous work, this invention explores polypeptides with sequence identity to IL-17 and IL-17 receptors, further enhancing the scope of treatments available for complex inflammatory conditions.

Career Highlights

Menno VanLookeren is proudly associated with Genentech, Inc., a leading biotechnology company renowned for its groundbreaking work in pharmaceuticals. His innovative research has not only contributed to the company's success but has also set new standards in the medical field.

Collaborations

In his career, Menno has collaborated with talented peers such as Jian Chen and Ellen Filvaroff. These partnerships are crucial in driving forward research goals and enhancing the development of effective therapies.

Conclusion

Menno VanLookeren stands out as a prominent inventor whose work continues to influence the landscape of therapeutic inventions. Through his patents and collaborative efforts in companies like Genentech, his contributions are poised to leave a lasting impact on the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…